Laura Melado Vidales: High-Specific AMH Assays Refine Assessment of Low Ovarian Reserve
Laura Melado Vidales, Medical Director ART Fertility Clinics Abu Dhabi at ART Fertility Clinics, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 14, 2026, 14:58Devyanshi Dixit։ Can We Measure Ovarian Age?
-
Oct 14, 2026, 14:56Rohit Gutgutia: The IVF Price War, and Who Really Pays for It
-
Oct 14, 2026, 14:54Abdullah F. Edrees։ Marking an Important Milestone for IVF
-
Oct 14, 2026, 14:50Gregory Poulos: Pleased to Be Named President of Vios Fertility 2.0
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?
-
Oct 13, 2026, 16:29IVI RMA Global Introduces IVI Fertility
-
Oct 13, 2026, 16:12Devyanshi Dixit: PCOS May Be One Diagnosis, But Is It One Biological Disease?